Buy tech sell-off, Wedbush’s Ives says: ’this is a 1996 moment, not 1999’
DUBLIN - Investment giant BlackRock, Inc. has disclosed a 1.61% stake in Mural Oncology plc, according to a regulatory filing published Monday.
The disclosure, made under Irish Takeover Panel rules, reveals that BlackRock holds 279,430 shares in the oncology-focused company as of September 19, 2025. This position consists of 279,415 owned or controlled relevant securities and 15 shares through cash-settled derivatives.
The filing also reported that BlackRock sold 4,630 shares of Mural Oncology at a price of $2.08 per share as part of recent transactions.
The disclosure was made in compliance with Rule 8.3 of the Irish Takeover Panel Act, which requires persons with interests in relevant securities representing 1% or more to disclose their positions.
BlackRock confirmed in the filing that it holds no short positions in Mural Oncology securities and is not making disclosures regarding any other party to an offer.
The information was provided through a Form 8.3 opening position disclosure submitted to the Regulatory Information Service, as required by Irish takeover regulations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.